Table 4 Relation between IGF rs6214 genotypes and different parameters in colorectal Cancer group (n = 80)
| Â | IGF rs6214 | Test of Sig | p | ||
|---|---|---|---|---|---|
CC (n = 12) | CT (n = 28) | TT (n = 40) | |||
Sex | |||||
 Male | 7 (58.3%) | 17 (60.7%) | 23 (57.5%) | χ2 = 0.071 | 0.965 |
 Female | 5 (41.7%) | 11 (39.3%) | 17 (42.5%) |  |  |
Age (years) | 11.6 ± 44.9 | 11.8 ± 46 | 12.6 ± 52.4 | F = 3.115 | 0.050 |
ALT | 4.6 ± 33.3 | 4.8 ± 32.6 | 4.3 ± 33.7 | F = 0.443 | 0.643 |
AST | 4.6 ± 32.1 | 4.2 ± 31.7 | 4.6 ± 30.9 | F = 0.450 | 0.639 |
UREA | 10.1 ± 30.2 | 10.2 ± 28.9 | 9.3 ± 28.7 | H = 0.314 | 0.855 |
Creatinine | 0.2 ± 1 | 0.2 ± 1 | 0.3 ± 1 | F = 0.285 | 0.753 |
CA19-9 (U/ml) | 6.9 ± 8.5 | 6.4 ± 10.5 | 72.9 ± 122.7 | H = 34.668* | < 0.001* |
CEA (mg/dl) | 1.6 ± 31.1 | 2.9 ± 33.5 | 23.4 ± 55.9 | H = 50.170* | < 0.001* |
Serum IGF-1 (ng/ml) | 1.9 ± 122.2 | 4.9 ± 131.6 | 32.6 ± 175.3 | F = 40.227* | < 0.001* |